Statistics for Ultraliferp (id:6898 ULBI)

Valuation metrics

Market cap

122.37M

Enterprise value

127.81M

Trailing P/E (ttm)

13.63

Forward P/E

8.18

PEG ratio

8.18

Price/Sales (ttm)

0.74

Price/Book (mrq)

0.91

Enterprise Value/Revenue

0.77

Enterprise Value/EBITDA

7.82

Overview

Shares outstanding

16.62M

Float

10.64M

Shares short

173.06K

% Held by insiders

0.03%

% Held by institutions

0.74%

Average volume (10 days)

98.97K

Average volume (90 days)

Price summary

52-Week low

6.36

52-Week high

13.39

52-Week change

-4.88%

Beta

0.98

50-Day moving average

8.97

200-Day moving average

9.86

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

5.44%

Operating margin

2.13%

Operational effectiveness

Return on assets

4.44%

Return on equity

7.04%

Income statement

Revenue (ttm)

10.02

Revenue per share (ttm)

10.02

Quarterly revenue growth (yoy)

-0.81

Gross profit (ttm)

39.20M

EBITDA

18.34M

Net income to common (ttm)

8.99M

Diluted EPS (ttm)

0.54

Quarterly earnings growth (yoy)

-80.60%

Balance sheet

Total cash (mrq)

6.77M

Total cash per share (mrq)

0.41

Total debt (mrq)

12.06M

Total Debt/Equity (mrq)

8.96

Current ratio (mrq)

329.80%

Book value per share (mrq)

8.09

Cash flow

Cash flow statement

16.02M

Levered free cash flow (LFCF)

9.15M